A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Early Phase 1

Active, not recruiting

• Conditions: Smoking
• Interventions: Behavioral: LungTalk

• Registration Number: NCT04848961
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communications and LungTalk, a web-based (accessed through the Internet) health communication tool that uses text, audio, video, and animation to increase awareness and knowledge about lung cancer screening. This study will focus on women who have recently received a screening mammogram.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-09
• Study First Submitted: 2021-04-09
• Study First Submitted QC: 2021-04-13
• Study First Posted: 2021-04-19
• Status Verified: 2025-04
• Last Update Submitted: 2025-05-14
• Last Update Posted: 2025-05-18
• Primary Completion: 2026-04-09
• Study Completion: 2026-04-09

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
• Age 50-80 years
• ≥ 20-pack-year smoking history of combustible cigarettes as per self report
• Women who currently smoke or quit within past 15 years as per self report
• Lung screening naïve as per self-report

Exclusion Criteria

• Lung cancer diagnosis
• Chest CT within the last 12 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Women who have had a mammogram	LungTalk	Participants will consist of eligible women who have had a mammogram

Primary Outcome Measures

Name	Time	Method
Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening	6 months	Develop a proactive digital outreach and engagement strategy to identify breast screening patients who are eligible for lung screening.

Trial Locations

Locations (8)

Memorial Sloan Kettering Bergen (Limited Protocol Activities); 🇺🇸 Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity); 🇺🇸 Commack, New York, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities); 🇺🇸 Harrison, New York, United States

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities); 🇺🇸 Uniondale, New York, United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities); 🇺🇸 Basking Ridge, New Jersey, United States

Hartford Healthcare Cancer Institute @ Hartford Hospital; 🇺🇸 Hartford, Connecticut, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities); 🇺🇸 Middletown, New Jersey, United States